Archived

This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.

Date Available

9-27-2022

Year of Publication

2021

Document Type

Article

Degree Name

Bachelors in Agricultural and Medical Biotechnology

College

Agriculture, Food and Environment

Department/School/Program

Agricultural and Medical Biotechnology

Faculty

Bjoern Bauer

Abstract

Epilepsy and Alzheimer’s disease are two prevalent neurological disorders. The blood-brain barrier (BBB) is a factor in why there are no long-term treatments for these diseases. The transporters in the neurovascular unit (NVU), which makes up the BBB, are highly specialized, so most drugs cannot pass the barrier to treat these diseases. It is unknown why drug uptake in the BBB varies in a diseased and wild-type brain, but one theory is that there are spatial differences in the NVU. One method for examining the NVU is the CLARITY tissue clearing technique which is unique in its capability to clear and image large quantities of tissue. Developing and optimizing the methods for the CLARITY tissue clearing process, antibody labeling, and imaging was the focus of this study. The images were quantitatively analyzed for percentage area antibody staining and qualitatively analyzed for morphological differences in the NVU.

Share

COinS